Consenso de especialistas (SBC/SBHCI) sobre o uso de stents farmacológicos: recomendações da sociedade brasileira de cardiologia/sociedade brasileira de hemodinâmica e cardiologia intervencionista ao sistema único de saúde

Lima, Valter C.; Mattos, Luiz Alberto; Caramori, Paulo; Perin, Marco Antônio; Mangione, José Armando; Machado, Bruno Martins; Coelho, Wilson; Bueno, Ronaldo R. L.

doi:10.1590/s0066-782x2006001700037

Cited by 7 publications

(6 citation statements)

References 45 publications

(26 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite the recommendations of the Brazilian Society of Hemodynamics and Interventional Cardiology, a significant percentage of patients are still treated with bare-metal stents. The National Health System has not yet incorporated the use of drug-eluting stents (DES) 3. Thus, bare-metal stents are the only option for percutaneous coronary interventions performed in our public health care system.…”

Section: Introductionmentioning

confidence: 99%

Influence of metal alloy and the profile of coronary stents in patients with multivessel coronary disease

Filho¹,

Forte²,

Sumita³

et al. 2011

Clinics

View full text Add to dashboard Cite

BACKGROUND:In Brazil, despite the recommendations of the Brazilian Society of Hemodynamics and Interventional Cardiology, the National Health System has not yet approved the use of drug-eluting stents. In percutaneous coronary interventions performed in the public and part of the private health care system, bare metal stents are used as the only option. Therefore, new information on bare metal stents is of great importance. The primary endpoint was to evaluate the influence of the alloy and the profile of coronary stents on late loss and restenosis rates 6 months after implantation in patients with multivessel coronary disease.METHODS:Single center, randomized and prospective study comparison of cobalt–chromium versus stainless steel stent implantation in 187 patients with multivessel coronary disease. At least one cobalt–chromium and one stainless steel stent were implanted per patient.RESULTS:Mean age of patients was 59.5±10.1 years with a prevalence of males (66.3%) and patients with acute coronary syndrome (56%). Baseline clinical characteristics were similar with hypertension in 146 (78%), dyslipidemia in 85 (45.5%) and diabetes in 68 (36.4%). Two hundred and twenty-nine cobalt–chromium and 284 stainless steel stents were implanted. Angiographic variables showed no statistically significant difference. Angiographic follow-up to 6 months after implantation showed similar late loss and restenosis rates.CONCLUSION:The use of two different alloys, stainless steel and cobalt–chrome stents, in the same patient and in the same vessel produced similar 6-month restenosis and late loss rates.

show abstract

Section: Introductionmentioning

confidence: 99%

Influence of metal alloy and the profile of coronary stents in patients with multivessel coronary disease

Filho¹,

Forte²,

Sumita³

et al. 2011

Clinics

View full text Add to dashboard Cite

show abstract

“…In view of the recommendation of guidelines 1,3 for the use of DES in diabetics, with level of evidence A and indication class II, these patients were grouped in a special subgroup to assess if the recommendations for stent placement are being followed during coronary angioplasty. A total of 199 diabetic patients were seen in the public service; of these, 47.7% had access to PA and, in most interventions (91.3%), bare metal stents were used, while only 8.7% used DES (p < 0.001).…”

Section: Resultsmentioning

confidence: 99%

“…It is also worth noting a remarkable overuse of bare metal stents with higher utility rates for the public service, which is in disagreement with the guidelines recommendations. 1,3…”

Section: Discussionmentioning

confidence: 99%

“…1,2 Coronary stent implantation is considered the device of choice for the completion of angioplasty because its use reduces the rates of acute vessel occlusion, and the need for late surgical revascularization when compared to the procedure performed with balloon alone. 3…”

Section: Introductionmentioning

confidence: 99%

“…1,5 Thus, the Brazilian Society of Hemodynamics and Interventional Cardiology (SBHCI) recommends the preferential use of the drug-eluting stent in diabetics, with evidence level A and indication class II, since these devices release substances that inhibit intimal hyperplasia of the treated vessel, further reducing the chances of restenosis. 1,3…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Disparities In The Use Of Drug-eluting Stents For Diabetic Patients With ST-elevation Acute Myocardial Infarction Assisted In the Public versus Private Network - VICTIM Register

Oliveira¹,

Oliveira²,

Oliveira³

et al. 2019

Arquivos Brasileiros De Cardiologia

View full text Add to dashboard Cite

Background Primary angioplasty (PA) with placement of either bare metal or drug-eluting stents (DES) represents the main strategy in the treatment of ST-elevation myocardial infarction (STEMI). Diabetic patients, however, represent a special population in STEMI, with high rates of restenosis and unfavorable clinical outcomes, and with the use of DES, level of evidence A and indication class II, being indicated to reduce these damages. Objectives To evaluate the DES rate of use in patients with STEMI and in the subgroup of diabetics assisted in the public versus private health network in Sergipe. Methods This is a population-based, cross-sectional study with a quantitative approach using the data from the VICTIM Register. These were collected in the only four hospitals with capacity to perform PA in Sergipe, from December 2014 to March 2017. Results A total of 707 patients diagnosed with STEMI were evaluated, of which 589 were attended at SUS and 118 at the private network. The use of DES in PA was lower in SUS compared to the private network in both the total sample (10.5% vs 82.4%, p<0.001) and in subgroup diabetic patients (8.7% vs 90.6%, p < 0.001), respectively. In all hypotheses tested, the level of significance was 5% (p < 0.05). Conclusions The study reveals a disparity in the use of DES during the performance of PA between the public and private network, both in the total sample and the subgroup for diabetics, with lower rates for SUS users, demonstrating the challenges that need to be overcome in order to achieve quality improvements of the services provided.

show abstract

Assessment of the use of clopidogrel associated with gastroprotective medications in outpatients

Galante

Santos

Cunha

2012

Farmacia Hospitalaria

View full text Add to dashboard Cite

show abstract

Consenso de especialistas (SBC/SBHCI) sobre o uso de stents farmacológicos: recomendações da sociedade brasileira de cardiologia/sociedade brasileira de hemodinâmica e cardiologia intervencionista ao sistema único de saúde

Cited by 7 publications

References 45 publications

Influence of metal alloy and the profile of coronary stents in patients with multivessel coronary disease

Influence of metal alloy and the profile of coronary stents in patients with multivessel coronary disease

Disparities In The Use Of Drug-eluting Stents For Diabetic Patients With ST-elevation Acute Myocardial Infarction Assisted In the Public versus Private Network - VICTIM Register

Assessment of the use of clopidogrel associated with gastroprotective medications in outpatients

Contact Info

Product

Resources

About